672 Randomised phase II trial (M77001) of trastuzumab (Herceptin®) plus docetaxel versus docetaxel alone, as first-line therapy in patients with HER2-positive metastitic breast cancer

Phase II Trial of Weekly Vinorelbine and Trastuzumab as First‐Line Therapy in Patients with HER2 + Metastatic Breast Cancer

The Oncologist ◽

10.1634/theoncologist.7-5-410 ◽

2002 ◽

Vol 7 (5) ◽

pp. 410-417 ◽

Cited By ~ 107

Author(s):

Mohammad Jahanzeb ◽

Joanne E. Mortimer ◽

Furhan Yunus ◽

David H. Irwin ◽

James Speyer ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

First Line ◽

First Line Therapy ◽

P1-14-01: Randomized Phase II Trial of Weekly vs. q 2-Weekly vs. q 3-Weekly Nanoparticle Albumin-Bound Paclitaxel with Bevacizumab as First-Line Therapy for Metastatic Breast Cancer.

10.1158/0008-5472.sabcs11-p1-14-01 ◽

2011 ◽

Author(s):

AD Seidman ◽

AK Conlin ◽

A Bach ◽

A Forero-Torres ◽

G Wright ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Randomized Phase Ii

LBA19 GEICAM/2014-12 (FLIPPER) study: First analysis from a randomized phase II trial of fulvestrant (F)/palbociclib (P) versus (vs) F/placebo (PL) as first-line therapy in postmenopausal women with HR (hormone receptor)+/HER2– endocrine sensitive advanced breast cancer (ABC)

Annals of Oncology ◽

10.1016/j.annonc.2020.08.2247 ◽

2020 ◽

Vol 31 ◽

pp. S1151

Author(s):

J. Albanell ◽

M.T.M. Martinez ◽

M. Ramos ◽

M.O.' Connor ◽

L. De la Cruz-Merino ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Postmenopausal Women ◽

Phase Ii ◽

Hormone Receptor ◽

Phase Ii Trial ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Randomized Phase Ii

Phase II trial of gefitinib combined with docetaxel as first-line therapy in patients with metastatic breast cancer

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.3080 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 3080-3080 ◽

Cited By ~ 4

Author(s):

F. Ciardiello ◽

T. Troiani ◽

F. Caputo ◽

M. de Laurentiis ◽

G. Tortora ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

First Line ◽

First Line Therapy ◽

Vinorelbine, methotrexate and fluorouracil (VMF) as first-line therapy in metastatic breast cancer: a randomized phase II trial

Annals of Oncology ◽

10.1093/annonc/mdg199 ◽

2003 ◽

Vol 14 (5) ◽

pp. 699-703 ◽

Cited By ~ 5

Author(s):

I. Elomaa ◽

H. Joensuu ◽

C. Blomqvist

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Randomized Phase Ii

A Phase II Trial of Docetaxel With Bevacizumab as First-line Therapy for HER2-Negative Metastatic Breast Cancer (TORI B01)

Clinical Breast Cancer ◽

10.3816/cbc.2010.n.040 ◽

2010 ◽

Vol 10 (4) ◽

pp. 307-312 ◽

Cited By ~ 8

Author(s):

Sara A. Hurvitz ◽

Heather J. Allen ◽

Rebecca L. Moroose ◽

David Chan ◽

Christopher Hagenstad ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

First Line ◽

First Line Therapy ◽

Randomized Phase II Trial of weekly paclitaxel alone versus trastuzumab plus weekly paclitaxel as first-line therapy of patients with Her-2 positive advanced breast cancer

Breast Cancer Research and Treatment ◽

10.1007/s10549-006-9306-9 ◽

2006 ◽

Vol 101 (3) ◽

pp. 355-365 ◽

Cited By ~ 92

Author(s):

Giampietro Gasparini ◽

Massimo Gion ◽

Luigi Mariani ◽

Paola Papaldo ◽

Diana Crivellari ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Weekly Paclitaxel ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Randomized Phase Ii ◽

Her 2

A multinational phase II study of Navelbine (N) and Herceptin (H) as first-line therapy for patients with HER2-positive metastatic breast cancer (HER2+ MBC)

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(04)90846-4 ◽

2004 ◽

Vol 2 (3) ◽

pp. 127 ◽

Cited By ~ 1

Author(s):

M Untch ◽

S Kahlert ◽

L Petruzelka ◽

M Martin ◽

V Guillem-Porta ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Breast ◽

First Line ◽

Her2 Positive ◽

First Line Therapy ◽

First-line therapy with metronomic capecitabine (mC) plus docetaxel (D) followed by mC as maintenance for patients with HER2-negative metastatic breast cancer (MBC): Preliminary analysis of a monocentric phase II trial.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.e11547 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. e11547-e11547 ◽

Cited By ~ 1

Author(s):

G. Aurilio ◽

A. Sciandivasci ◽

E. Munzone ◽

D. F. Riva ◽

D. Radice ◽

...

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Preliminary Analysis ◽

Phase Ii Trial ◽

Metastatic Breast ◽

First Line ◽

First Line Therapy ◽

Reply to “Letter to the Editor on ‘Vinorelbine, methotrexate and fluorouracil (VMF) as first line therapy in metastatic breast cancer: a randomised phase II trial’”, by B. Isik and K. Altundag (Ann Oncol 2004; 15: 175)

Annals of Oncology ◽

10.1093/annonc/mdh024 ◽

2004 ◽

Vol 15 (1) ◽

pp. 175

Author(s):

C. Blomqvist

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Metastatic Breast ◽

First Line ◽

First Line Therapy ◽

Line Therapy ◽

Letter To The Editor